{"id":348970,"date":"2025-08-25T16:11:09","date_gmt":"2025-08-25T16:11:09","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-rapt-therapeutics\/"},"modified":"2025-08-25T16:11:09","modified_gmt":"2025-08-25T16:11:09","slug":"how-to-buy-rapt-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/","title":{"rendered":"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334090,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-348970","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"RAPT Therapeutics hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin; g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 piyasa f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131.","description_source":{"label":"Description","type":"textarea","formatted_value":"RAPT Therapeutics hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin; g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 piyasa f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131."},"intro":"\u0130leri teknoloji biyoteknoloji yeniliklerine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? RAPT Therapeutics, t\u0131bbi at\u0131l\u0131mlar\u0131n ola\u011fan\u00fcst\u00fc yat\u0131r\u0131m getirilerine d\u00f6n\u00fc\u015febilece\u011fi imm\u00fcnoloji ara\u015ft\u0131rmalar\u0131n\u0131n heyecan verici s\u0131n\u0131r\u0131n\u0131 temsil ediyor. Bu klinik a\u015famadaki \u015firket, inflamatuar hastal\u0131klar ve kanser i\u00e7in devrim niteli\u011finde tedaviler geli\u015ftiriyor ve sa\u011fl\u0131k sekt\u00f6r\u00fcnde b\u00fcy\u00fcme arayan yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir f\u0131rsat sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130leri teknoloji biyoteknoloji yeniliklerine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? RAPT Therapeutics, t\u0131bbi at\u0131l\u0131mlar\u0131n ola\u011fan\u00fcst\u00fc yat\u0131r\u0131m getirilerine d\u00f6n\u00fc\u015febilece\u011fi imm\u00fcnoloji ara\u015ft\u0131rmalar\u0131n\u0131n heyecan verici s\u0131n\u0131r\u0131n\u0131 temsil ediyor. Bu klinik a\u015famadaki \u015firket, inflamatuar hastal\u0131klar ve kanser i\u00e7in devrim niteli\u011finde tedaviler geli\u015ftiriyor ve sa\u011fl\u0131k sekt\u00f6r\u00fcnde b\u00fcy\u00fcme arayan yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir f\u0131rsat sunuyor."},"body_html":"<h2>\ud83d\udcc8 RAPT Hisse Analizi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla, RAPT Therapeutics (RAPT) NASDAQ borsas\u0131nda <strong>11,32 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi, 2025 boyunca klinik a\u015famadaki biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n hem risklerini hem de f\u0131rsatlar\u0131n\u0131 yans\u0131tan dikkat \u00e7ekici bir volatilite sergiledi.<\/p> <p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong><br \/> Bu tarih, RAPT yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in son derece kritik. \u015eirket, 2025 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve tarihsel olarak bu t\u00fcr olaylar \u00f6nemli fiyat hareketlerine yol a\u00e7t\u0131. 7 A\u011fustos kazan\u00e7 a\u00e7\u0131klama modeline dayanarak, bu tarihte \u00f6nemli volatilite bekleyebiliriz.<\/p> <p><strong>Tarihsel Kazan\u00e7 Etkisi Analizi:<\/strong><\/p> <ul> <li>7 A\u011fustos 2025: 2. \u00c7eyrek Kazan\u00e7lar\u0131 - Hisse, g\u00fc\u00e7l\u00fc 168,9 milyon $ nakit pozisyonuna ra\u011fmen kar\u0131\u015f\u0131k tepki verdi<\/li> <li>\u00d6nceki \u00e7eyrekler tipik biyoteknoloji modeli g\u00f6steriyor: Klinik deneme duyurular\u0131 etraf\u0131nda %15-25 fiyat dalgalanmalar\u0131<\/li> <li>\u015eirketin 13 Haziran 2025'te yapt\u0131\u011f\u0131 1'e 8 ters hisse b\u00f6l\u00fcnmesi ek teknik volatilite yaratt\u0131<\/li> <\/ul> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu: Kurtarmal\u0131 Rollercoaster<\/h2> <p>RAPT hisselerinin \u015eubat-A\u011fustos 2025 performans\u0131 olduk\u00e7a dramatikti:<\/p> <ul> <li><strong>\u015eubat-Mart 2025<\/strong>: Yat\u0131r\u0131mc\u0131lar klinik deneme g\u00fcncellemelerini beklerken hisse 8-10 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<\/li> <li><strong>Nisan 2025<\/strong>: Sekt\u00f6r genelinde biyoteknoloji duyarl\u0131l\u0131\u011f\u0131ndaki de\u011fi\u015fimle volatilite artt\u0131<\/li> <li><strong>15 May\u0131s 2025<\/strong>: Kritik dip nokta <strong>5,67 $<\/strong> - 52 haftal\u0131k en d\u00fc\u015f\u00fck<\/li> <li><strong>Haziran 2025<\/strong>: Ters hisse b\u00f6l\u00fcnmesi ve yenilenen yat\u0131r\u0131mc\u0131 g\u00fcveniyle toparlanma ba\u015flad\u0131<\/li> <li><strong>Temmuz-A\u011fustos 2025<\/strong>: Fiyatlar 11-12 $ aral\u0131\u011f\u0131na ula\u015farak g\u00fc\u00e7l\u00fc yukar\u0131 y\u00f6nl\u00fc ivme kazand\u0131<\/li> <li><strong>G\u00fcncel Performans<\/strong>: Son bir ayda %29,01 art\u0131\u015f, ancak y\u0131lba\u015f\u0131ndan bu yana %11,00 d\u00fc\u015f\u00fc\u015f<\/li> <\/ul> <p>5,67 $ ile 26,56 $ aras\u0131ndaki 52 haftal\u0131k aral\u0131k, volatiliteyi anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel, cesareti az olanlar i\u00e7in ise korkutucu ger\u00e7ek bir biyoteknoloji rollercoaster hikayesi anlat\u0131yor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Kapsaml\u0131 analist konsens\u00fcs\u00fc ve klinik deneme tetikleyicilerine dayanarak beklentiler \u015funlard\u0131r:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 23-28 $ aral\u0131\u011f\u0131 (%100-150 y\u00fckseli\u015f potansiyeli)<br \/> <em>Tetikleyiciler: Kronik spontan \u00fcrtiker ve ast\u0131m i\u00e7in RPT904 Faz 2 deneme sonu\u00e7lar\u0131<\/em><\/li> <li><strong>2026 Tahmini<\/strong>: 30-40 $ aral\u0131\u011f\u0131 (ba\u015far\u0131l\u0131 deneme sonu\u00e7lar\u0131na ba\u011fl\u0131)<br \/> <em>Faz 2 sonu\u00e7lar\u0131 g\u00fc\u00e7l\u00fc olursa FDA \u00f6nc\u00fc atama potansiyeli<\/em><\/li> <li><strong>2028 Projeksiyonu<\/strong>: 50-70 $ aral\u0131\u011f\u0131 (ba\u015far\u0131l\u0131 Faz 3 denemeleri varsay\u0131larak)<br \/> <em>G\u0131da alerjisi tedavisine piyasa geni\u015flemesi de\u011ferlemeyi art\u0131rabilir<\/em><\/li> <li><strong>2030 Uzun Vadeli<\/strong>: 80-100+ $ (tam ticarile\u015fme ger\u00e7ekle\u015firse)<br \/> <em>\u00c7ok milyar dolarl\u0131k imm\u00fcnoloji pazarlar\u0131nda blockbuster ila\u00e7 potansiyeli<\/em><\/li> <\/ul> <p><strong>Sonu\u00e7: 3-5 y\u0131ll\u0131k ufku olan risk toleransl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM<\/strong><\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Biyoteknoloji Volatilitesinde Yol Alma<\/h2> <h3>Y\u00fcksek Olas\u0131l\u0131kl\u0131 Riskler:<\/h3> <ul> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: \u0130la\u00e7 adaylar\u0131n\u0131n %90'\u0131 ba\u015far\u0131s\u0131z oluyor - RPT904 da bunlara kat\u0131labilir<\/li> <li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA durdurmalar\u0131 veya reddi an\u0131nda %50+ de\u011fer kayb\u0131 yaratabilir<\/li> <li><strong>Nakit Yakma Endi\u015feleri<\/strong>: \u00c7eyreklik 34,8 milyon $ zarar s\u0131k s\u0131k fonlama gerektiriyor<\/li> <li><strong>Sekt\u00f6r Duyarl\u0131l\u0131\u011f\u0131<\/strong>: Biyoteknoloji hisseleri genellikle bireysel performanstan ba\u011f\u0131ms\u0131z birlikte hareket eder<\/li> <\/ul> <h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler:<\/h3> <ul> <li><strong>168,9 Milyon $ Nakit Pozisyonu<\/strong>: Mevcut yakma oran\u0131nda 12+ ay \u00e7al\u0131\u015fma s\u00fcresi sa\u011fl\u0131yor<\/li> <li><strong>\u00c7oklu Tetikleyiciler<\/strong>: 2025 ikinci yar\u0131s\u0131nda iki endikasyon i\u00e7in Faz 2 sonu\u00e7lar\u0131<\/li> <li><strong>Deneyimli Liderlik<\/strong>: Yeni y\u00f6netim kurulu \u00fcyeleri ve klinik ekip y\u00fcr\u00fctmeyi g\u00fc\u00e7lendiriyor<\/li> <li><strong>Sekt\u00f6r Ortakl\u0131klar\u0131<\/strong>: Jemincare ile i\u015f birli\u011fi geli\u015ftirme maliyetlerini azalt\u0131yor<\/li> <li><strong>Piyasa Zamanlamas\u0131<\/strong>: \u0130mm\u00fcnoloji sekt\u00f6r\u00fc artan yat\u0131r\u0131mc\u0131 ilgisi g\u00f6r\u00fcyor<\/li> <\/ul> <h2>\ud83d\udcca \u00d6nemli Haber Etkisi Analizi<\/h2> <p>Her yat\u0131r\u0131mc\u0131n\u0131n anlamas\u0131 gereken son geli\u015fmeler:<\/p> <p><strong>7 A\u011fustos 2025 - 2. \u00c7eyrek Kazan\u00e7 Raporu<\/strong><br \/> \u015eirket, Ar-Ge harcamalar\u0131nda azalma ile iyile\u015fen finansal g\u00f6stergeler bildirdi (12,3 milyon $ vs 22,6 milyon $ y\u0131ll\u0131k). 34,8 milyon $ net zarar baz\u0131 yat\u0131r\u0131mc\u0131lar\u0131 endi\u015felendirse de, g\u00fc\u00e7l\u00fc 168,9 milyon $ nakit pozisyonu operasyonlar\u0131n devam\u0131 i\u00e7in g\u00fcven verdi.<\/p> <p><strong>Haziran 2025 - Liderlik G\u00fc\u00e7lendirmesi<\/strong><br \/> Dr. Scott Braunstein ve Dr. Ashley Dombkowski'nin y\u00f6netim kuruluna atanmas\u0131 \u00f6nemli sekt\u00f6r deneyimi getirdi. Bu hamle, ba\u015far\u0131l\u0131 ila\u00e7 geli\u015ftirmeye ciddi ba\u011fl\u0131l\u0131\u011f\u0131 i\u015faret etti.<\/p> <p><strong>Devam Eden - Klinik Deneme \u0130lerlemesi<\/strong><br \/> Kronik spontan \u00fcrtiker ve ast\u0131m i\u00e7in RPT904'\u00fcn beklenen Faz 2 sonu\u00e7lar\u0131 en \u00f6nemli k\u0131sa vadeli tetikleyiciler. Olumlu veriler hisse fiyat\u0131n\u0131 \u00fc\u00e7 kat\u0131na \u00e7\u0131karabilirken, olumsuz sonu\u00e7lar yar\u0131 yar\u0131ya d\u00fc\u015f\u00fcrebilir.<\/p> <h2>\ud83c\udfaf Yeni Ba\u015flayan Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Bug\u00fcnk\u00fc Eylem Plan\u0131<\/h2> <p><strong>Ciddi \u00d6neriler:<\/strong><\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn en fazla %2-3'\u00fcn\u00fc ba\u015flang\u0131\u00e7ta RAPT'a ay\u0131r\u0131n<\/li> <li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Tek seferde de\u011fil, par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li> <li><strong>Uyar\u0131lar Kurun<\/strong>: 11 Kas\u0131m kazan\u00e7lar\u0131 ve klinik deneme duyurular\u0131n\u0131 takip edin<\/li> <li><strong>\u00c7\u0131k\u0131\u015f Stratejisi Belirleyin<\/strong>: Girmeden \u00f6nce zarar durdurma noktalar\u0131n\u0131z\u0131 bilin<\/li> <\/ol> <p><strong>Esprili Tecr\u00fcbeli Tavsiyesi:<\/strong><br \/> \"RAPT ticareti yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir - at\u0131l\u0131mlar yapt\u0131klar\u0131nda inan\u0131lmaz heyecan verici, ama deneyler ba\u015far\u0131s\u0131z oldu\u011funda duygusal \u00e7alkant\u0131ya haz\u0131rl\u0131kl\u0131 olun. Kazan\u00e7 g\u00fcn\u00fc i\u00e7in her zaman biraz \u00e7ikolata ve sert bir i\u00e7ki bulundurun!\"<\/p> <h2>\u2705 RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ listeleri ve kesirli hisse sunan bir platform oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"RAPT\" Aramas\u0131 Yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, tam borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in L\u0130M\u0130T emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td><td>Kazan\u00e7lar ve klinik deneme haberlerini takip edin<\/td><\/tr> <tr><td>7<\/td><td>Tezinizi Belgeleyin<\/td><td>Gelecek referanslar i\u00e7in neden sat\u0131n ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Biyoteknoloji Yat\u0131r\u0131mlar\u0131nda Neden \u00d6ne \u00c7\u0131k\u0131yor<\/h2> <p>RAPT Therapeutics hisselerini ticaret yapmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option, biyoteknoloji yat\u0131r\u0131mlar\u0131 i\u00e7in \u00f6zellikle de\u011ferli olan belirgin avantajlar sunar:<\/p> <ul> <li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> - Y\u00fcksek riskli biyoteknoloji hisselerinde stratejileri test etmek i\u00e7in m\u00fckemmel, b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc gerektirmez<\/li> <li><strong>Y\u0131ld\u0131r\u0131m H\u0131z\u0131nda KYC<\/strong> - Tek belge do\u011frulamas\u0131 sayesinde kritik biyoteknoloji haber pencerelerinde hemen ticarete ba\u015flayabilirsiniz<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong> - 100'den fazla y\u00f6ntem, klinik deneme sonu\u00e7lar\u0131 geldi\u011finde karlar\u0131n\u0131za h\u0131zl\u0131 eri\u015fim sa\u011flar<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, RAPT'\u0131n volatil fiyat hareketlerini izlemek ve kazan\u00e7 a\u00e7\u0131klamalar\u0131 ile klinik deneme veri yay\u0131nlar\u0131 etraf\u0131nda h\u0131zl\u0131 i\u015flemler yapmak i\u00e7in idealdir.<\/p> <h2>\ud83e\uddec RAPT Therapeutics: \u0130mm\u00fcnoloji Yenilik\u00e7isi<\/h2> <p>RAPT Therapeutics, inflamatuar hastal\u0131klardan muzdarip milyonlarca ki\u015fi i\u00e7in tedaviyi devrim niteli\u011finde de\u011fi\u015ftirebilecek yeni terapiler geli\u015ftiren imm\u00fcnoloji ara\u015ft\u0131rmalar\u0131n\u0131n \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirketin, belirli molek\u00fcler mekanizmalar\u0131 hedef alan hassas t\u0131p yakla\u015f\u0131mlar\u0131na odaklanmas\u0131, geleneksel geni\u015f spektrum tedavilerden ayr\u0131lmas\u0131n\u0131 sa\u011fl\u0131yor.<\/p> <ul> <li><strong>Mevcut Piyasa Konumu<\/strong>: 171-187 milyon $ piyasa de\u011feri olan mikro kap biyoteknoloji \u015firketi<\/li> <li><strong>Temel Teknoloji<\/strong>: Ba\u011f\u0131\u015f\u0131kl\u0131k sistemi yollar\u0131n\u0131 hedef alan oral k\u00fc\u00e7\u00fck molek\u00fcl ila\u00e7lar<\/li> <li><strong>\u00d6nc\u00fc Aday<\/strong>: Alerjik hastal\u0131klar i\u00e7in yar\u0131 \u00f6mr\u00fc uzat\u0131lm\u0131\u015f monoklonal antikor RPT904<\/li> <li><strong>\u00dcr\u00fcn \u00c7e\u015fitlili\u011fi<\/strong>: Hem imm\u00fcnoloji hem de onkoloji alanlar\u0131nda programlar, riski azalt\u0131yor<\/li> <\/ul> <p><strong>\u0130lgin\u00e7 2025 Ger\u00e7e\u011fi<\/strong>: RAPT ara\u015ft\u0131rma ekibi, \u00f6nc\u00fc bile\u015fiklerinin g\u0131da alerjisi modellerinde beklenmedik etkinlik g\u00f6sterdi\u011fini ke\u015ffetti; bu, orijinal geli\u015ftirme planlar\u0131n\u0131n d\u0131\u015f\u0131nda \u00e7ok milyar dolarl\u0131k bir pazar a\u00e7abilir. Bu tesad\u00fcfi ke\u015fif, en b\u00fcy\u00fck f\u0131rsatlar\u0131 olabilir!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 RAPT Hisse Analizi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla, RAPT Therapeutics (RAPT) NASDAQ borsas\u0131nda <strong>11,32 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi, 2025 boyunca klinik a\u015famadaki biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n hem risklerini hem de f\u0131rsatlar\u0131n\u0131 yans\u0131tan dikkat \u00e7ekici bir volatilite sergiledi.<\/p>\n<p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong><br \/> Bu tarih, RAPT yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in son derece kritik. \u015eirket, 2025 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve tarihsel olarak bu t\u00fcr olaylar \u00f6nemli fiyat hareketlerine yol a\u00e7t\u0131. 7 A\u011fustos kazan\u00e7 a\u00e7\u0131klama modeline dayanarak, bu tarihte \u00f6nemli volatilite bekleyebiliriz.<\/p>\n<p><strong>Tarihsel Kazan\u00e7 Etkisi Analizi:<\/strong><\/p>\n<ul>\n<li>7 A\u011fustos 2025: 2. \u00c7eyrek Kazan\u00e7lar\u0131 &#8211; Hisse, g\u00fc\u00e7l\u00fc 168,9 milyon $ nakit pozisyonuna ra\u011fmen kar\u0131\u015f\u0131k tepki verdi<\/li>\n<li>\u00d6nceki \u00e7eyrekler tipik biyoteknoloji modeli g\u00f6steriyor: Klinik deneme duyurular\u0131 etraf\u0131nda %15-25 fiyat dalgalanmalar\u0131<\/li>\n<li>\u015eirketin 13 Haziran 2025&#8217;te yapt\u0131\u011f\u0131 1&#8217;e 8 ters hisse b\u00f6l\u00fcnmesi ek teknik volatilite yaratt\u0131<\/li>\n<\/ul>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu: Kurtarmal\u0131 Rollercoaster<\/h2>\n<p>RAPT hisselerinin \u015eubat-A\u011fustos 2025 performans\u0131 olduk\u00e7a dramatikti:<\/p>\n<ul>\n<li><strong>\u015eubat-Mart 2025<\/strong>: Yat\u0131r\u0131mc\u0131lar klinik deneme g\u00fcncellemelerini beklerken hisse 8-10 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<\/li>\n<li><strong>Nisan 2025<\/strong>: Sekt\u00f6r genelinde biyoteknoloji duyarl\u0131l\u0131\u011f\u0131ndaki de\u011fi\u015fimle volatilite artt\u0131<\/li>\n<li><strong>15 May\u0131s 2025<\/strong>: Kritik dip nokta <strong>5,67 $<\/strong> &#8211; 52 haftal\u0131k en d\u00fc\u015f\u00fck<\/li>\n<li><strong>Haziran 2025<\/strong>: Ters hisse b\u00f6l\u00fcnmesi ve yenilenen yat\u0131r\u0131mc\u0131 g\u00fcveniyle toparlanma ba\u015flad\u0131<\/li>\n<li><strong>Temmuz-A\u011fustos 2025<\/strong>: Fiyatlar 11-12 $ aral\u0131\u011f\u0131na ula\u015farak g\u00fc\u00e7l\u00fc yukar\u0131 y\u00f6nl\u00fc ivme kazand\u0131<\/li>\n<li><strong>G\u00fcncel Performans<\/strong>: Son bir ayda %29,01 art\u0131\u015f, ancak y\u0131lba\u015f\u0131ndan bu yana %11,00 d\u00fc\u015f\u00fc\u015f<\/li>\n<\/ul>\n<p>5,67 $ ile 26,56 $ aras\u0131ndaki 52 haftal\u0131k aral\u0131k, volatiliteyi anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel, cesareti az olanlar i\u00e7in ise korkutucu ger\u00e7ek bir biyoteknoloji rollercoaster hikayesi anlat\u0131yor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Kapsaml\u0131 analist konsens\u00fcs\u00fc ve klinik deneme tetikleyicilerine dayanarak beklentiler \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 23-28 $ aral\u0131\u011f\u0131 (%100-150 y\u00fckseli\u015f potansiyeli)<br \/> <em>Tetikleyiciler: Kronik spontan \u00fcrtiker ve ast\u0131m i\u00e7in RPT904 Faz 2 deneme sonu\u00e7lar\u0131<\/em><\/li>\n<li><strong>2026 Tahmini<\/strong>: 30-40 $ aral\u0131\u011f\u0131 (ba\u015far\u0131l\u0131 deneme sonu\u00e7lar\u0131na ba\u011fl\u0131)<br \/> <em>Faz 2 sonu\u00e7lar\u0131 g\u00fc\u00e7l\u00fc olursa FDA \u00f6nc\u00fc atama potansiyeli<\/em><\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 50-70 $ aral\u0131\u011f\u0131 (ba\u015far\u0131l\u0131 Faz 3 denemeleri varsay\u0131larak)<br \/> <em>G\u0131da alerjisi tedavisine piyasa geni\u015flemesi de\u011ferlemeyi art\u0131rabilir<\/em><\/li>\n<li><strong>2030 Uzun Vadeli<\/strong>: 80-100+ $ (tam ticarile\u015fme ger\u00e7ekle\u015firse)<br \/> <em>\u00c7ok milyar dolarl\u0131k imm\u00fcnoloji pazarlar\u0131nda blockbuster ila\u00e7 potansiyeli<\/em><\/li>\n<\/ul>\n<p><strong>Sonu\u00e7: 3-5 y\u0131ll\u0131k ufku olan risk toleransl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM<\/strong><\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Biyoteknoloji Volatilitesinde Yol Alma<\/h2>\n<h3>Y\u00fcksek Olas\u0131l\u0131kl\u0131 Riskler:<\/h3>\n<ul>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: \u0130la\u00e7 adaylar\u0131n\u0131n %90&#8217;\u0131 ba\u015far\u0131s\u0131z oluyor &#8211; RPT904 da bunlara kat\u0131labilir<\/li>\n<li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA durdurmalar\u0131 veya reddi an\u0131nda %50+ de\u011fer kayb\u0131 yaratabilir<\/li>\n<li><strong>Nakit Yakma Endi\u015feleri<\/strong>: \u00c7eyreklik 34,8 milyon $ zarar s\u0131k s\u0131k fonlama gerektiriyor<\/li>\n<li><strong>Sekt\u00f6r Duyarl\u0131l\u0131\u011f\u0131<\/strong>: Biyoteknoloji hisseleri genellikle bireysel performanstan ba\u011f\u0131ms\u0131z birlikte hareket eder<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler:<\/h3>\n<ul>\n<li><strong>168,9 Milyon $ Nakit Pozisyonu<\/strong>: Mevcut yakma oran\u0131nda 12+ ay \u00e7al\u0131\u015fma s\u00fcresi sa\u011fl\u0131yor<\/li>\n<li><strong>\u00c7oklu Tetikleyiciler<\/strong>: 2025 ikinci yar\u0131s\u0131nda iki endikasyon i\u00e7in Faz 2 sonu\u00e7lar\u0131<\/li>\n<li><strong>Deneyimli Liderlik<\/strong>: Yeni y\u00f6netim kurulu \u00fcyeleri ve klinik ekip y\u00fcr\u00fctmeyi g\u00fc\u00e7lendiriyor<\/li>\n<li><strong>Sekt\u00f6r Ortakl\u0131klar\u0131<\/strong>: Jemincare ile i\u015f birli\u011fi geli\u015ftirme maliyetlerini azalt\u0131yor<\/li>\n<li><strong>Piyasa Zamanlamas\u0131<\/strong>: \u0130mm\u00fcnoloji sekt\u00f6r\u00fc artan yat\u0131r\u0131mc\u0131 ilgisi g\u00f6r\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udcca \u00d6nemli Haber Etkisi Analizi<\/h2>\n<p>Her yat\u0131r\u0131mc\u0131n\u0131n anlamas\u0131 gereken son geli\u015fmeler:<\/p>\n<p><strong>7 A\u011fustos 2025 &#8211; 2. \u00c7eyrek Kazan\u00e7 Raporu<\/strong><br \/> \u015eirket, Ar-Ge harcamalar\u0131nda azalma ile iyile\u015fen finansal g\u00f6stergeler bildirdi (12,3 milyon $ vs 22,6 milyon $ y\u0131ll\u0131k). 34,8 milyon $ net zarar baz\u0131 yat\u0131r\u0131mc\u0131lar\u0131 endi\u015felendirse de, g\u00fc\u00e7l\u00fc 168,9 milyon $ nakit pozisyonu operasyonlar\u0131n devam\u0131 i\u00e7in g\u00fcven verdi.<\/p>\n<p><strong>Haziran 2025 &#8211; Liderlik G\u00fc\u00e7lendirmesi<\/strong><br \/> Dr. Scott Braunstein ve Dr. Ashley Dombkowski&#8217;nin y\u00f6netim kuruluna atanmas\u0131 \u00f6nemli sekt\u00f6r deneyimi getirdi. Bu hamle, ba\u015far\u0131l\u0131 ila\u00e7 geli\u015ftirmeye ciddi ba\u011fl\u0131l\u0131\u011f\u0131 i\u015faret etti.<\/p>\n<p><strong>Devam Eden &#8211; Klinik Deneme \u0130lerlemesi<\/strong><br \/> Kronik spontan \u00fcrtiker ve ast\u0131m i\u00e7in RPT904&#8217;\u00fcn beklenen Faz 2 sonu\u00e7lar\u0131 en \u00f6nemli k\u0131sa vadeli tetikleyiciler. Olumlu veriler hisse fiyat\u0131n\u0131 \u00fc\u00e7 kat\u0131na \u00e7\u0131karabilirken, olumsuz sonu\u00e7lar yar\u0131 yar\u0131ya d\u00fc\u015f\u00fcrebilir.<\/p>\n<h2>\ud83c\udfaf Yeni Ba\u015flayan Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Bug\u00fcnk\u00fc Eylem Plan\u0131<\/h2>\n<p><strong>Ciddi \u00d6neriler:<\/strong><\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn en fazla %2-3&#8217;\u00fcn\u00fc ba\u015flang\u0131\u00e7ta RAPT&#8217;a ay\u0131r\u0131n<\/li>\n<li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Tek seferde de\u011fil, par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li>\n<li><strong>Uyar\u0131lar Kurun<\/strong>: 11 Kas\u0131m kazan\u00e7lar\u0131 ve klinik deneme duyurular\u0131n\u0131 takip edin<\/li>\n<li><strong>\u00c7\u0131k\u0131\u015f Stratejisi Belirleyin<\/strong>: Girmeden \u00f6nce zarar durdurma noktalar\u0131n\u0131z\u0131 bilin<\/li>\n<\/ol>\n<p><strong>Esprili Tecr\u00fcbeli Tavsiyesi:<\/strong><br \/> &#8220;RAPT ticareti yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir &#8211; at\u0131l\u0131mlar yapt\u0131klar\u0131nda inan\u0131lmaz heyecan verici, ama deneyler ba\u015far\u0131s\u0131z oldu\u011funda duygusal \u00e7alkant\u0131ya haz\u0131rl\u0131kl\u0131 olun. Kazan\u00e7 g\u00fcn\u00fc i\u00e7in her zaman biraz \u00e7ikolata ve sert bir i\u00e7ki bulundurun!&#8221;<\/p>\n<h2>\u2705 RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ listeleri ve kesirli hisse sunan bir platform oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;RAPT&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, tam borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in L\u0130M\u0130T emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td>\n<td>Kazan\u00e7lar ve klinik deneme haberlerini takip edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Tezinizi Belgeleyin<\/td>\n<td>Gelecek referanslar i\u00e7in neden sat\u0131n ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Biyoteknoloji Yat\u0131r\u0131mlar\u0131nda Neden \u00d6ne \u00c7\u0131k\u0131yor<\/h2>\n<p>RAPT Therapeutics hisselerini ticaret yapmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option, biyoteknoloji yat\u0131r\u0131mlar\u0131 i\u00e7in \u00f6zellikle de\u011ferli olan belirgin avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> &#8211; Y\u00fcksek riskli biyoteknoloji hisselerinde stratejileri test etmek i\u00e7in m\u00fckemmel, b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc gerektirmez<\/li>\n<li><strong>Y\u0131ld\u0131r\u0131m H\u0131z\u0131nda KYC<\/strong> &#8211; Tek belge do\u011frulamas\u0131 sayesinde kritik biyoteknoloji haber pencerelerinde hemen ticarete ba\u015flayabilirsiniz<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong> &#8211; 100&#8217;den fazla y\u00f6ntem, klinik deneme sonu\u00e7lar\u0131 geldi\u011finde karlar\u0131n\u0131za h\u0131zl\u0131 eri\u015fim sa\u011flar<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, RAPT&#8217;\u0131n volatil fiyat hareketlerini izlemek ve kazan\u00e7 a\u00e7\u0131klamalar\u0131 ile klinik deneme veri yay\u0131nlar\u0131 etraf\u0131nda h\u0131zl\u0131 i\u015flemler yapmak i\u00e7in idealdir.<\/p>\n<h2>\ud83e\uddec RAPT Therapeutics: \u0130mm\u00fcnoloji Yenilik\u00e7isi<\/h2>\n<p>RAPT Therapeutics, inflamatuar hastal\u0131klardan muzdarip milyonlarca ki\u015fi i\u00e7in tedaviyi devrim niteli\u011finde de\u011fi\u015ftirebilecek yeni terapiler geli\u015ftiren imm\u00fcnoloji ara\u015ft\u0131rmalar\u0131n\u0131n \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirketin, belirli molek\u00fcler mekanizmalar\u0131 hedef alan hassas t\u0131p yakla\u015f\u0131mlar\u0131na odaklanmas\u0131, geleneksel geni\u015f spektrum tedavilerden ayr\u0131lmas\u0131n\u0131 sa\u011fl\u0131yor.<\/p>\n<ul>\n<li><strong>Mevcut Piyasa Konumu<\/strong>: 171-187 milyon $ piyasa de\u011feri olan mikro kap biyoteknoloji \u015firketi<\/li>\n<li><strong>Temel Teknoloji<\/strong>: Ba\u011f\u0131\u015f\u0131kl\u0131k sistemi yollar\u0131n\u0131 hedef alan oral k\u00fc\u00e7\u00fck molek\u00fcl ila\u00e7lar<\/li>\n<li><strong>\u00d6nc\u00fc Aday<\/strong>: Alerjik hastal\u0131klar i\u00e7in yar\u0131 \u00f6mr\u00fc uzat\u0131lm\u0131\u015f monoklonal antikor RPT904<\/li>\n<li><strong>\u00dcr\u00fcn \u00c7e\u015fitlili\u011fi<\/strong>: Hem imm\u00fcnoloji hem de onkoloji alanlar\u0131nda programlar, riski azalt\u0131yor<\/li>\n<\/ul>\n<p><strong>\u0130lgin\u00e7 2025 Ger\u00e7e\u011fi<\/strong>: RAPT ara\u015ft\u0131rma ekibi, \u00f6nc\u00fc bile\u015fiklerinin g\u0131da alerjisi modellerinde beklenmedik etkinlik g\u00f6sterdi\u011fini ke\u015ffetti; bu, orijinal geli\u015ftirme planlar\u0131n\u0131n d\u0131\u015f\u0131nda \u00e7ok milyar dolarl\u0131k bir pazar a\u00e7abilir. Bu tesad\u00fcfi ke\u015fif, en b\u00fcy\u00fck f\u0131rsatlar\u0131 olabilir!<\/p>\n"},"faq":[{"question":"RAPT Therapeutics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"RAPT\" sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve fiyat uyar\u0131lar\u0131 kurarak geli\u015fmeleri takip edin."},{"question":"RAPT Therapeutics'in riskleri nelerdir?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, reg\u00fclasyon engelleri, nakit yakma ve sekt\u00f6r duyarl\u0131l\u0131\u011f\u0131 gibi y\u00fcksek riskler bulunmaktad\u0131r."},{"question":"RAPT Therapeutics'in 2025 sonu fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda hisse fiyat\u0131 23-28 $ aral\u0131\u011f\u0131nda olabilir, bu %100-150 y\u00fckseli\u015f potansiyeline i\u015faret eder."},{"question":"RAPT Therapeutics'in lider \u00fcr\u00fcn\u00fc nedir?","answer":"RPT904, alerjik hastal\u0131klar i\u00e7in yar\u0131 \u00f6mr\u00fc uzat\u0131lm\u0131\u015f monoklonal antikordur."},{"question":"Pocket Option biyoteknoloji yat\u0131r\u0131mlar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum yat\u0131r\u0131m, h\u0131zl\u0131 KYC ve \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ile biyoteknoloji hisselerinde h\u0131zl\u0131 ve esnek i\u015flem yapmay\u0131 sa\u011flar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"RAPT Therapeutics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"RAPT\" sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve fiyat uyar\u0131lar\u0131 kurarak geli\u015fmeleri takip edin."},{"question":"RAPT Therapeutics'in riskleri nelerdir?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, reg\u00fclasyon engelleri, nakit yakma ve sekt\u00f6r duyarl\u0131l\u0131\u011f\u0131 gibi y\u00fcksek riskler bulunmaktad\u0131r."},{"question":"RAPT Therapeutics'in 2025 sonu fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda hisse fiyat\u0131 23-28 $ aral\u0131\u011f\u0131nda olabilir, bu %100-150 y\u00fckseli\u015f potansiyeline i\u015faret eder."},{"question":"RAPT Therapeutics'in lider \u00fcr\u00fcn\u00fc nedir?","answer":"RPT904, alerjik hastal\u0131klar i\u00e7in yar\u0131 \u00f6mr\u00fc uzat\u0131lm\u0131\u015f monoklonal antikordur."},{"question":"Pocket Option biyoteknoloji yat\u0131r\u0131mlar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum yat\u0131r\u0131m, h\u0131zl\u0131 KYC ve \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ile biyoteknoloji hisselerinde h\u0131zl\u0131 ve esnek i\u015flem yapmay\u0131 sa\u011flar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T16:11:09+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T16:11:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/\",\"name\":\"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"datePublished\":\"2025-08-25T16:11:09+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T16:11:09+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T16:11:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/","name":"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r - RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","datePublished":"2025-08-25T16:11:09+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rapt-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"RAPT Therapeutics, Inc. (RAPT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RAPT Therapeutics, Inc. (RAPT) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":348965,"slug":"how-to-buy-rapt-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu RAPT Therapeutics, Inc. (RAPT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu RAPT Therapeutics, Inc. (RAPT)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapt-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":348963,"slug":"how-to-buy-rapt-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da RAPT Therapeutics, Inc. (RAPT) - Investimento em a\u00e7\u00f5es da RAPT Therapeutics, Inc. (RAPT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-rapt-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/348970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=348970"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/348970\/revisions"}],"predecessor-version":[{"id":348971,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/348970\/revisions\/348971"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334090"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=348970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=348970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=348970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}